Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018164

Expand all

ANAPROX DS (NAPROXEN SODIUM)
EQ 500MG BASE
Marketing Status: Prescription

Active Ingredient: NAPROXEN SODIUM
Proprietary Name: ANAPROX DS
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 500MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N018164
Product Number: 003
Approval Date: Sep 30, 1987
Applicant Holder Full Name: ATNAHS PHARMA US LTD
Marketing Status:  Prescription
Patent and Exclusivity Information

ANAPROX (NAPROXEN SODIUM)
EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued

Active Ingredient: NAPROXEN SODIUM
Proprietary Name: ANAPROX
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N018164
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: ATNAHS PHARMA US LTD
Marketing Status:  Discontinued
Patent and Exclusivity Information